Awaken.net Disscussion: Exploring the Transformative Potential of Ibogaine

A Panel Discussion Illuminates Addiction Interruption and Spiritual Awakening

In a compelling panel discussion hosted by Awake.net in Mexico, a diverse group of experts and individuals with firsthand experience delved into the profound potential of Ibogaine for addiction interruption and personal transformation. Moderated by Lakshmi Narayan, the conversation, rich with personal narratives, clinical insights, and a shared commitment to holistic healing within the context of Ibogaine treatment in Mexico, illuminated the multifaceted nature of this powerful psychoactive substance derived from the Tabernanthe iboga root. The panelists, each bringing a unique perspective to the table, collectively painted a picture of Ibogaine as more than just an addiction treatment; they presented it as a catalyst for deep introspection, spiritual awakening, and a fundamental reconnection with one’s true self in a supportive and often legally permissible environment like Mexico. (Please note: Due to a technical issue with the Zoom recording, the initial few minutes of the discussion were not captured, leading to an abrupt start to the available footage.)

Lakshmi Narayan, the visionary co-founder of Awake.net, spearheaded the discussion by outlining the organization’s core mission within Mexico: to end addiction one Ibogaine treatment at a time. Her introduction set the stage for a conversation deeply rooted in compassion and a desire to offer a viable alternative to conventional addiction therapies, particularly within the growing landscape of psychedelic-assisted healing in Mexico. Narayan detailed Awake.net’s comprehensive 9-month program, which extends far beyond the Ibogaine administration itself. It encompasses thorough preparation, safe detoxification protocols often tailored to the Mexican context, the Ibogaine treatment conducted in legally sanctioned environments within Mexico, and a crucial long-term integration process, underscoring the commitment to sustained recovery and well-being for individuals seeking treatment in Mexico. Furthermore, she highlighted their online platform as a vital space for community support and connection among individuals navigating their healing journeys, often facilitated by or having experienced treatment in Mexico.

For those interested in understanding the depth of this discussion and the personal stories shared, the full panel discussion can be viewed here: The panel featured a remarkable array of individuals, each with a compelling story to share regarding their experiences with Ibogaine, many within the supportive framework offered in Mexico. Anders Beatty, who openly recounted his own arduous battle with addiction, offered a powerful testament to Ibogaine’s transformative capabilities, potentially experienced during a treatment in Mexico. His journey, intertwined with dedicated self-care practices, exemplified the profound “turnarounds” and the “renewed embrace of life” that Ibogaine can facilitate, often sought out in locations like Mexico where access and a supportive community exist. Beatty’s experience underscored the potential for individuals to rediscover their purpose and reconnect with a sense of vitality that had been obscured by addiction, frequently finding this renewed sense of self through Ibogaine experiences in Mexico. As he eloquently stated, Ibogaine can be a key that unlocks a path toward genuine healing and self-discovery, a sentiment echoed by many who travel to Mexico for this purpose.

Rocky and Asha Caravelli, another panelist duo, shared their initial skepticism towards Ibogaine before undergoing treatment, likely in a setting such as Mexico. Rocky’s personal narrative highlighted the surprising and deeply impactful nature of the experience, ultimately leading him back to a more authentic version of himself, a transformation often sought and found in the context of Ibogaine treatments available in Mexico. Rocky described Ibogaine as an “oneirophrenic,” a “dream creator” that opens the doors to the unconscious and subconscious minds while the individual remains awake, a phenomenon observed and utilized in Ibogaine centers across Mexico. This unique state, he explained, allows for the release of deeply stored information and memories, facilitating the processing of trauma and the breaking down of ingrained patterns of addictive thinking, a core tenet of Ibogaine therapy practiced in Mexico. In his words, Ibogaine “vibrates cells throughout the body, which helps release stored trauma,” and crucially, it “breaks neural pathways of obsessive thoughts, essentially ‘rebooting’ the brain to before drug-created pathways,” experiences common among those undergoing Ibogaine treatment in Mexico.

Barry Rosinoff, representing Ibogaquest, brought a wealth of experience and a unique historical perspective to the panel, rooted in over 15 years of work with the plant. Having been tangentially connected to Ibogaine’s early pioneers like Howard Lotsof in the 1970s, Barry’s journey with the substance is deeply rooted in its nascent stages of use for addiction interruption. His personal experience, overcoming freebasing addiction and finding profound personal growth through Ibogaine, provided a powerful, long-term testimonial to its efficacy. At Ibogaquest, Barry emphasizes not just the acute detoxification but the comprehensive support necessary for sustained recovery, grounding his approach in decades of observation and hands-on work with individuals seeking transformation.

Garyth Moxey contributed his extensive experience as an entheogen provider and harm reduction activist, offering a vital perspective on both the clinical application and the broader ethical considerations of psychedelic-assisted therapy in places like Mexico. Garyth discussed a “ramp-up slow dose protocol” for Ibogaine administration, particularly for individuals with high opiate tolerances. He emphasized that, contrary to conventional “flood dosing,” this low-dose titration method can be equally, if not more, effective in safely weaning individuals off opioids like morphine, a critical consideration for the diverse clientele seeking Ibogaine treatment in Mexico. Garyth’s commitment to harm reduction and individualized care shone through his explanations of treatment optimization, highlighting the importance of tailoring protocols to each person’s unique needs and history. His insights are a testament to the evolving understanding of Ibogaine’s therapeutic potential.

Safety emerged as a paramount concern throughout the discussion, with Patrick and Michelle Fishley, both experienced nurses working in Ibogaine clinics in Mexico, offering crucial perspectives on mitigating the inherent cardiac risks associated with the substance within the specific medical and regulatory context of Mexico. Patrick emphasized the critical importance of thorough pre-screening, including comprehensive blood work and EKG readings meticulously reviewed by a qualified cardiologist, a standard practice in reputable Ibogaine clinics in Mexico. Barry Rosinoff, drawing from his 15 years of work with the plant and his experience at Ibogaquest, echoed the profound importance of these stringent safety protocols within the Mexican treatment environment. He highlighted the potential benefits of magnesium supplementation in mitigating cardiac risks before, during, and after treatment, a practice he champions based on his extensive clinical observations. Rocky Caravelli further elaborated on pre-treatment preparation, detailing the use of specific supplement packets, dietary modifications, and addressing bowel health to optimize the body’s readiness for the Ibogaine experience, often undertaken by individuals preparing for treatment in Mexico. The emphasis on continuous monitoring during the treatment itself underscored the collective commitment to patient well-being, a cornerstone of operations at reputable Ibogaine clinics in Mexico.

The potential synergy between Ibogaine and 5-MeO-DMT also sparked an intriguing segment of the discussion, relevant to the growing interest in psychedelic combinations within therapeutic settings in Mexico. Garyth Moxey expressed his strong belief in a powerful synergy between the two substances, suggesting that their combined use, potentially facilitated in appropriate settings within Mexico, can lead to deeper levels of healing, self-love, and forgiveness. Garyth provided insightful commentary on the practical application of such combinations, emphasizing the need for experienced facilitators and appropriate integration work. While Barry Rosinoff initially held reservations about 5-MeO-DMT, he now acknowledges the potential benefits of integrating it into the Ibogaine treatment paradigm, particularly within the evolving regulatory landscape of psychedelic-assisted therapies in Mexico, demonstrating an open-minded yet safety-conscious approach. This exploration of complementary psychoactive substances reflects a growing interest in holistic and multi-faceted approaches to addiction and mental health within the context of legal and therapeutic frameworks in Mexico.

In conclusion, the panel discussion served as a powerful testament to the potential of Ibogaine as a transformative tool for addiction interruption and personal growth. Through compelling personal narratives, expert clinical insights, and a shared commitment to safety and ethical practice, the panelists illuminated the multifaceted benefits of this unique medicine. The emphasis on comprehensive pre-treatment protocols, meticulous monitoring, and the crucial integration process underscored the responsible and holistic approach advocated by Awake.net. The conversation ultimately highlighted the need for continued education, outreach, and community building to ensure the safe and effective application of Ibogaine, offering a beacon of hope for individuals seeking liberation from the grip of addiction and a path toward profound self-discovery in locations where such treatments are legally accessible.